Results 121 to 130 of about 31,542 (255)

Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsies. [PDF]

Histopathology
Ding CC, Xiao H, Nguyen JK, Przybycin CG, Alaghehbandan R, Myles JL, Greenland NY, Simko JP, Sirohi D, Stohr BA, McKenney JK.   +10 more
europepmc   +1 more source

Cuproptosis Inducers in Cancer Therapy: State of the Art and Challenges

The Chemical Record, EarlyView.
Cuproptosis is emerging as a distinct copper‐dependent cell death pathway, highlighting copper as a potential metabolic vulnerability in cancer. This review examines how coordination chemistry, redox regulation, and nanomaterial design shape Cu reactivity and therapeutic outcomes.
Chiara Ragusa, Valentina Oliveri
wiley   +1 more source

Hypertrophic Osteopathy Associated with a Prostatic Adenocarcinoma in a Castrated Dog. [PDF]

Vet Sci, 2022
Roux FA, Deseille E, Fusellier M, Rohel M, Branchereau J, Deschamps JY.   +5 more
europepmc   +1 more source

Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine

VIEW, EarlyView.
Nanobodies, derived from the variable domains of camelid heavy‐chain‐only antibodies, have emerged as transformative biomedical tools due to their nanoscale size, exceptional stability, and unique capacity to recognize cryptic epitopes. This review provides a comprehensive overview of the field, outlining the structural and biochemical features of ...
Zhenrui Ye, Xianyang Li, Meixiao Zhan
wiley   +1 more source

Simultaneous Lymphoepithelioma-Like and Plasmacytoid Subtypes of Urothelial Carcinoma, Along With Prostatic Adenocarcinoma With Clinical Follow-Up. [PDF]

Case Rep Pathol
Venkatesh S, Costanza JS, Cox B, Finch C, Xu Y.   +4 more
europepmc   +1 more source

Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study. [PDF]

Asian Pac J Cancer Prev, 2023
Sayed RMS, El Shorbagy G, Shibel PEE.
europepmc   +1 more source

Prostate Adenocarcinoma

Background: Prostate adenocarcinoma is the most common malignancy in men in Italy, with generally favorable survival rates when detected early. Despite multiple treatment options, disease recurrence remains a clinical challenge. Case Presentation: Reported the case of a 78-year-old male with recurrent prostate adenocarcinoma initially diagnosed in ...
openaire   +2 more sources

Apo10 and TKTL1 as novel liquid biopsy biomarkers for early detection of gastrointestinal malignancies

VIEW, EarlyView.
(A) Overview of the study population and schematic illustration showing tumor‐derived apoptotic and metabolic biomarkers, Apo10 and TKTL1, being phagocytosed by circulating monocytes and subsequently detected in peripheral blood. (B) Illustration of the epitope detection in monocytes (EDIM) strategy, using a flow‐cytometric gating approach based on ...
Zhiying Mao, Qiyu Huang, Juan Xiao, Ziyu Liu, Xinyan Zou, Yuying Liu, Lizhi Liu, Musheng Zeng, Chuanbo Xie   +8 more
wiley   +1 more source

Concurrent prostatic stromal tumor of uncertain malignant potential and prostatic adenocarcinoma: A case report exhibiting advantages of a Multidisciplinary Team. [PDF]

Urol Case Rep
Andersen ND, Jochumsen MR, Nielsen TF, Graff SM, Berg KD, Larsen FE.   +5 more
europepmc   +1 more source

Prostatic adenocarcinoma with transitional cell features among the Saudi Arabian population: a registry review. [PDF]

Ann Med Surg (Lond), 2023
Ghazwani Y, Sabbah BN, Algahfees MA, Arabi TZ, Alageel AK, Musalli ZF, Almutairi ES, Alasker A.   +7 more
europepmc   +1 more source